Case Report: Mitochondrial insufficiency underlies cholinergic failure in post-vaccination long COVID: a candidate treatment protocol - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Clinical Case Study: Mitochondrial Dysfunction as a Cause of Cholinergic Impairment in Long COVID Post-Vaccination: Proposed Treatment Approach

  • By

  • Tom Goulding

  • July 21, 2026

Share

  • 1

    An 80-year-old male with severe long COVID experienced acute deterioration after COVID-19 vaccination despite ongoing cholinergic therapy.

  • 2

    A comprehensive mitochondrial support protocol was initiated, targeting NAD+ repletion and oxidative stress, delivered in fresh-squeezed orange juice.

  • 3

    Clinical response was dramatic within 48 hours, with sustained functional recovery over 6 weeks following the protocol.

  • 4

    Challenge-rechallenge testing revealed that citric acid from orange juice was essential for the protocol's efficacy, indicating substrate limitation.

  • 5

    This case suggests that cholinergic support may require concurrent metabolic foundation, with some long COVID manifestations potentially metabolically reversible.

Original Source(s)

Case Report: Mitochondrial insufficiency underlies cholinergic failure in post-vaccination long COVID: a candidate treatment protocol

  • by Tom Goulding

  • July 21, 2026

Related Content

FDA approves XFG-adapted COVID-19 vaccine

The 2026 to 2027 formulation aligns with FDA guidance on the preferred composition for COVID-19 vaccines beginning this fall.

Pneumonia Etiology and Risk Factors in a Tertiary Hospital During the COVID-19 Era: A Retrospective Analysis (2020–2024)

Same-Day COVID, Flu Vaccination Appears Safe

Study found no increased 90-day risk of serious adverse events with coadministration compared with vaccination alone.